Bank of New York Mellon’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241M Buy
498,996
+23,476
+5% +$6.23M 0.04% 369
2026
Q1
$52.1M Sell
475,520
-25,922
-5% -$3.69M 0.01% 975
2025
Q4
$83.4M Sell
501,442
-11,243
-2% -$1.88M 0.01% 738
2025
Q3
$100M Sell
512,685
-9,408
-2% -$1.55M 0.02% 642
2025
Q2
$47.2M Buy
522,093
+133,961
+35% +$10.6M 0.01% 1034
2025
Q1
$23.2M Buy
388,132
+4,935
+1% +$457K ﹤0.01% 1417
2024
Q4
$50.8M Buy
383,197
+212,055
+124% +$19.9M 0.01% 1015
2024
Q3
$8.97M Buy
171,142
+32,964
+24% +$1.55M ﹤0.01% 1982
2024
Q2
$8.36M Buy
+138,178
New +$9.58M ﹤0.01% 2054

Other funds holding ALAB

Bank of New York Mellon's ALAB Position: Q2 2026 in Review

Bank of New York Mellon increased its Astera Labs (ALAB) stake by 4.9% in Q2 2026, buying an estimated $6.23M and bringing the position to 498,996 shares worth $241M. The position accounts for 0.04% of the portfolio, ranked #369.

Bank of New York Mellon first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Bank of New York Mellon held 498,996 shares of Astera Labs worth $241M as of Q2 2026.
  • Bank of New York Mellon bought 23,476 Astera Labs shares in Q2 2026, an estimated $6.23M.
  • Astera Labs made up 0.04% of Bank of New York Mellon's portfolio in Q2 2026, its #369 holding.
  • Bank of New York Mellon first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.